Elixinol Global Limited Annual Report 2020

Q3 FY2020 Elixinol announces an agreement with PharmaCann to sell cannabidiol (CBD) products in the Australian market through the Therapeutic Goods Administration’s (TGA’s) Special Access Scheme (SAS) Distribution with Well Pharmacy commenced, with 8 Elixinol branded products selling in more than 500 stores across the UK Elixinol’s skincare range, “elixinolSkin” launches in Boots Pharmacy’s throughout Ireland Hemp Foods Australia performance and growth improvement continues, contributing 25% of total revenue in Q3 FY2020 Signs an exclusive Trademark and Know- How License Agreement with Elixinol Japan, ensuring Elixinol can continue to build on its market leadership position in Japan Helen Wiseman appointed Chair of Elixinol Global, bringing strong governance and leadership skillset; Paul Benhaimmoves to Non-Executive Director role Q4 FY2020 Elixinol launches its new Good Mood CBD Gummies range Successful Placement raising $8.2 million, with strong support from new and existing institutional and sophisticated investors Heavily oversubscribed capital raise provides new funding of $20.5m COVID-19 impacting retail channels in key markets Hemp Foods Australia delivers above expectations, contributing revenue of $1.1m in Q4 FY2020 Advancements in marketing and web services improved e-commerce customer acquisition with a 10% increase in new site users and 20% higher conversion rate First Elixinol product shipped under new product listing with SuperDrug, UK’s second largest health and beauty retailer Pet Releaf supply agreement terminated but Elixinol continues to be major shareholder First Hemp Foods Australia product shipped under new product listing with global retailer and warehouse hub Costco United Nations’ Commission on Narcotic Drugs (CND) votes to accept the World Health Organisation’s recommendation to down-schedule cannabis – this is expected to have a substantial, positive impact on Elixinol’s ability to drive product sales in Europe and other countries influenced by UN decision-making Company Overview Financial Report Shareholder Information 9 FY2020 Milestones F Y2020 MI LES TONES Strategy and Market Update